Dingley KH - Search Results

1

Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo.

Brown K, Guenther EA, Dingley KH, Cosman M, Harvey CA, Shields SJ, Turteltaub KW. Brown K, et al. Among authors: dingley kh. Nucleic Acids Res. 2001 May 1;29(9):1951-9. doi: 10.1093/nar/29.9.1951. Nucleic Acids Res. 2001. PMID: 11328879 Free PMC article.

2

Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans.

Wang Y, Villalta PW, Peng L, Dingley K, Malfatti MA, Turteltaub KW, Turesky RJ. Wang Y, et al. Chem Res Toxicol. 2017 Feb 20;30(2):705-714. doi: 10.1021/acs.chemrestox.6b00426. Epub 2017 Jan 18. Chem Res Toxicol. 2017. PMID: 27984695 Free PMC article.

3

DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Dingley KH, Curtis KD, Nowell S, Felton JS, Lang NP, Turteltaub KW. Dingley KH, et al. Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):507-12. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10385140

4

Characterization of a peptide adduct formed by N-acetoxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), a reactive intermediate of the food carcinogen PhIP.

Chepanoske CL, Brown K, Turteltaub KW, Dingley KH. Chepanoske CL, et al. Among authors: dingley kh. Food Chem Toxicol. 2004 Aug;42(8):1367-72. doi: 10.1016/j.fct.2003.11.012. Food Chem Toxicol. 2004. PMID: 15207388

5

Accelerator mass spectrometry for biomedical research.

Brown K, Dingley KH, Turteltaub KW. Brown K, et al. Among authors: dingley kh. Methods Enzymol. 2005;402:423-43. doi: 10.1016/S0076-6879(05)02014-8. Methods Enzymol. 2005. PMID: 16401518 Review.

6

The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans.

Malfatti MA, Dingley KH, Nowell-Kadlubar S, Ubick EA, Mulakken N, Nelson D, Lang NP, Felton JS, Turteltaub KW. Malfatti MA, et al. Among authors: dingley kh. Cancer Res. 2006 Nov 1;66(21):10541-7. doi: 10.1158/0008-5472.CAN-06-1573. Cancer Res. 2006. PMID: 17079477

7

Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.

Dingley KH, Freeman SP, Nelson DO, Garner RC, Turteltaub KW. Dingley KH, et al. Drug Metab Dispos. 1998 Aug;26(8):825-8. Drug Metab Dispos. 1998. PMID: 9698300

8

Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.

Dingley KH, Roberts ML, Velsko CA, Turteltaub KW. Dingley KH, et al. Chem Res Toxicol. 1998 Oct;11(10):1217-22. doi: 10.1021/tx9801458. Chem Res Toxicol. 1998. PMID: 9778319

9

Application of accelerated mass spectrometry (AMS) in DNA adduct quantification and identification.

Turteltaub KW, Dingley KH. Turteltaub KW, et al. Among authors: dingley kh. Toxicol Lett. 1998 Dec 28;102-103:435-9. doi: 10.1016/s0378-4274(98)00344-0. Toxicol Lett. 1998. PMID: 10022292

10

The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans.

Malfatti MA, Kulp KS, Knize MG, Davis C, Massengill JP, Williams S, Nowell S, MacLeod S, Dingley KH, Turteltaub KW, Lang NP, Felton JS. Malfatti MA, et al. Among authors: dingley kh. Carcinogenesis. 1999 Apr;20(4):705-13. doi: 10.1093/carcin/20.4.705. Carcinogenesis. 1999. PMID: 10223203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters